Market Cap

Mabpharm Ltd Market Capitalization:

HK$2.14 Billion

HKD as of Jan. 1, 2026

US$275.5 Million

business Mabpharm Ltd Company Profile

Mabpharm Ltd Main Stock Listing

HKEX: 2181

Market Capitalization History of Mabpharm Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Mabpharm Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2026 HK$2.14 B 103.92%
Jan. 1, 2025 HK$1.05 B -43.33%
Jan. 1, 2024 HK$1.86 B 0.00%
Jan. 1, 2023 HK$1.86 B -53.61%
Jan. 1, 2022 HK$4.00 B -8.49%
Jan. 1, 2021 HK$4.37 B 12.77%
Jan. 1, 2020 HK$3.88 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Mabpharm Ltd Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

Mabpharm Ltd has the following listings and related stock indices.


Stock: HKEX: 2181

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.